title: Chinese medicinal herbs for influenza.
abstract: BACKGROUND
  Influenza is a communicable acute respiratory infection which, during epidemics, can cause high morbidity and mortality rates. Traditional Chinese medicinal herbs, often administered following a particular Chinese medical theory, may be a potential treatment of choice.
  
  
  OBJECTIVE
  To assess the effect of Chinese medicinal herbs used to prevent and treat influenza and to estimate the frequency of adverse effects.
  
  
  METHODS
  We searched CENTRAL (2012, Issue 11), MEDLINE (January 1966 to November week 2, 2012), EMBASE (January 1988 to November 2012) and CNKI (January 1988 to 29 March 2012). We also searched reference lists of articles and the WHO ICTRP search portal (November 2012).
  
  
  METHODS
  Randomised controlled trials (RCTs) comparing traditional Chinese medicinal herbs with placebo, no treatment or conventional medicine normally used in preventing and treating uncomplicated influenza.
  
  
  METHODS
  Two review authors independently extracted data and assessed trial quality.
  
  
  RESULTS
  We included 18 studies involving 2521 participants. The methodological quality of 17 included studies was poor. Included RCTs separately compared medicinal herbs with different antiviral drugs, precluding any pooling of results. Only three indicated that compared with antiviral drugs, Chinese medicinal herbs may be effective in preventing influenza and alleviating influenza symptoms. 'Ganmao' capsules were found to be more effective than amantadine in decreasing influenza symptoms and speeding recovery in one study (in which adverse reactions were mentioned in the amantadine group although no data were reported). There were no significant differences between 'E Shu You' and ribavirin in treating influenza, nor in the occurrence of adverse reactions. Ten studies reported mild adverse reactions.
  
  
  CONCLUSIONS
  Most Chinese medical herbs in the included studies showed similar effects to antiviral drugs in preventing or treating influenza. Few were shown to be superior to antiviral drugs. No obvious adverse events were reported in the included studies. However, current evidence remains weak due to methodological limitations of the trials. More high-quality RCTs with larger numbers of participants and clear reporting are needed.
authors.affiliation: Chinese Evidence-Based Medicine Centre, West China Hospital, Sichuan University, Chengdu, China.
authors.forename: Lanhui
authors.initials: L
authors.lastname: Jiang
authors.forename: Linyu
authors.initials: L
authors.lastname: Deng
authors.forename: Taixiang
authors.initials: T
authors.lastname: Wu
mesh_terms: D000547:Amantadine / Q000627:therapeutic use; D000998:Antiviral Agents / Q000627:therapeutic use; D004365:Drugs, Chinese Herbal / Q000009:adverse effects / Q000627:therapeutic use*; D006801:Humans; D007251:Influenza, Human / Q000188:drug therapy*; D008517:Phytotherapy / Q000009:adverse effects / Q000379:methods*; D016032:Randomized Controlled Trials as Topic; D012254:Ribavirin / Q000627:therapeutic use
chemical_list: D000998:Antiviral Agents; D004365:Drugs, Chinese Herbal; D012254:Ribavirin; D000547:Amantadine
references.citation: BMJ. 1994 May 21;308(6940):1341-5
references.pmid: 8019225
references.citation: Phytomedicine. 2007 Feb;14(2-3):96-101
references.pmid: 17141491
references.citation: MMWR Recomm Rep. 2006 Jul 28;55(RR-10):1-42
references.pmid: 16874296
references.citation: Cochrane Database Syst Rev. 2008 Jan 23;(1):CD002745
references.pmid: 18254006
references.citation: Cochrane Database Syst Rev. 2005 Jan 25;(1):CD004559
references.pmid: 15674953
references.citation: J Altern Complement Med. 2000 Aug;6(4):327-34
references.pmid: 10976979
references.citation: Cochrane Database Syst Rev. 2012 Apr 18;(4):CD002744
references.pmid: 22513907
references.citation: Phytomedicine. 2007 Jan;14(1):11-4
references.pmid: 16644196
references.citation: Respir Med. 2010 Sep;104(9):1362-9
references.pmid: 20573492
references.citation: Cochrane Database Syst Rev. 2007 Oct 17;(4):CD004559
references.pmid: 17943819
references.citation: N Engl J Med. 2005 Dec 22;353(25):2633-6
references.pmid: 16371626
references.citation: Vaccine. 1998 May-Jun;16(9-10):977-8
references.pmid: 9682346
references.citation: Cochrane Database Syst Rev. 2012 Jan 18;1:CD008965
references.pmid: 22258996
references.citation: Ann Intern Med. 2011 Aug 16;155(4):217-25
references.pmid: 21844547